PrEParing Providers: The Next Challenge in Implementing Human Immunodeficiency Virus Preexposure Prophylaxis

被引：4
|
作者：
Hurt, Christopher B. [1 ,2 ]
机构：
[1] Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, North Carolina AIDS Training & Educ Ctr, Chapel Hill, NC 27515 USA
来源：
SEXUALLY TRANSMITTED DISEASES | 2018年 / 45卷 / 07期
关键词：
UNITED-STATES; CARE PROVIDERS; PREP; KNOWLEDGE; ATTITUDES; ADULTS; MEN; SEX;
D O I：
10.1097/OLQ.0000000000000835
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：459 / 461
页数：3
相关论文
共 50 条
  • [31] Iowa TelePrEP: A Public-Health-Partnered Telehealth Model for Human Immunodeficiency Virus Preexposure Prophylaxis Delivery in a Rural State
    Hoth, Angela B.
    Shafer, Cody
    Dillon, Dena Behm
    Mayer, Randy
    Walton, George
    Ohl, Michael E.
    SEXUALLY TRANSMITTED DISEASES, 2019, 46 (08) : 507 - 512
  • [32] Early Adopters of Human Immunodeficiency Virus Preexposure Prophylaxis in a Population-based Combination Prevention Study in Rural Kenya and Uganda
    Koss, Catherine A.
    Ayieko, James
    Mwangwa, Florence
    Owaraganise, Asiphas
    Kwarisiima, Dalsone
    Balzer, Laura B.
    Plenty, Albert
    Sang, Norton
    Kabami, Jane
    Ruel, Theodore D.
    Black, Douglas
    Camlin, Carol S.
    Cohen, Craig R.
    Bukusi, Elizabeth A.
    Clark, Tamara D.
    Charlebois, Edwin D.
    Petersen, Maya L.
    Kamya, Moses R.
    Havlir, Diane V.
    CLINICAL INFECTIOUS DISEASES, 2018, 67 (12) : 1853 - 1860
  • [33] Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide for Human Immunodeficiency Virus Preexposure Prophylaxis at a Boston Community Health Center
    Marcus, Julia L.
    Levine, Kenneth
    Sewell, Whitney C.
    Solleveld, Patricia
    Mayer, Kenneth H.
    Krakower, Douglas S.
    OPEN FORUM INFECTIOUS DISEASES, 2021, 8 (08):
  • [34] Is Higher Adherence Required for Women Using Oral Emtricitabine/Tenofovir Disoproxil Fumarate for Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis?
    Niu, Xin
    Drain, Paul K.
    CLINICAL INFECTIOUS DISEASES, 2024, 78 (03) : 801 - 802
  • [35] The Cost-effectiveness of Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis and HIV Testing Strategies in High-risk Groups in India
    Kazemian, Pooyan
    Costantini, Sydney
    Kumarasamy, Nagalingeswaran
    Paltiel, A. David
    Mayer, Kenneth H.
    Chandhiok, Nomita
    Walensky, Rochelle P.
    Freedberg, Kenneth A.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (04) : 633 - 642
  • [36] Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study
    Jenness, Samuel M.
    Weiss, Kevin M.
    Goodreau, Steven M.
    Gift, Thomas
    Chesson, Harrell
    Hoover, Karen W.
    Smith, Dawn K.
    Liu, Albert Y.
    Sullivan, Patrick S.
    Rosenberg, Eli S.
    CLINICAL INFECTIOUS DISEASES, 2017, 65 (05) : 712 - 718
  • [37] Vital Signs: Status of Human Immunodeficiency Virus Testing, Viral Suppression, and HIV Preexposure Prophylaxis - United States, 2013-2018
    Harris, Norma S.
    Johnson, Anna Satcher
    Huang, Ya-Lin A.
    Kern, Dayle
    Fulton, Paul
    Smith, Dawn K.
    Valleroy, Linda A.
    Hall, H. Irene
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2019, 68 (48): : 1117 - 1123
  • [38] Am I Positive? Improving Human Immunodeficiency Virus Testing in the Era of Preexposure Prophylaxis and Immediate Antiretroviral Therapy Using Machine Learning
    Zucker, Jason
    Carnevale, Caroline
    Gordon, Peter
    Sobieszczyk, Magdalena E.
    Rai, Alex J.
    OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (07):
  • [39] Impact of Providing Preexposure Prophylaxis for Human Immunodeficiency Virus at Clinics for Sexually Transmitted Infections in Baltimore City: An Agent-based Model
    Kasaie, Parastu
    Berry, Stephen A.
    Shah, Maunank S.
    Rosenberg, Eli S.
    Hoover, Karen W.
    Gift, Thomas L.
    Chesson, Harrell
    Pennington, Jeff
    German, Danielle
    Flynn, Colin P.
    Beyrer, Chris
    Dowdy, David W.
    SEXUALLY TRANSMITTED DISEASES, 2018, 45 (12) : 791 - 797
  • [40] Prophylaxis for opportunistic infections in patients with human immunodeficiency virus
    Katlama, C
    Jouan, M
    MEDECINE ET MALADIES INFECTIEUSES, 1996, 26 (8-9): : 742 - 751
12345